Literature DB >> 32169380

Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen.

David Larson1, Piyush Patel2, Anne Marie Salapatek2, Peter Couroux2, Don Whitehouse3, Adela Pina4, Jacqueline L Johnson4, Michelle L Sever4, Srinath Sanda3, Julian Poyser5, Theresa Allio5, Guy W Scadding6, Tielin Qin7, Mohamed H Shamji8, William W Kwok9, Eddie A James9, Deanna French10, Alina Lelic11, Mark Larché12, Matthew C Altman13, Alkis Togias5, Stephen R Durham8.   

Abstract

BACKGROUND: The direct-instillation nasal allergen challenge (NAC) and the environmental exposure chamber (EEC) are 2 methods of conducting controlled allergen provocations. The clinical and biological comparability of these methods has not been thoroughly investigated.
OBJECTIVE: We sought to compare clinical and immunologic responses to cat allergen in NAC versus EEC.
METHODS: Twenty-four participants were randomized to receive either NAC followed by a 2-day challenge in an EEC or a 2-day challenge in an EEC followed by NAC. Challenges were separated by 28-day washout periods. We measured total nasal symptom scores, peak nasal inspiratory flow, nasal (0-8 hours) and serum cytokines, serum antibodies, peripheral blood antigen-specific T lymphocytes, and gene expression in nasal scrapings. The primary outcome was the total nasal symptom score area under the curve for the first 3 hours after allergen exposure in NAC or after initiation of exposure in EEC.
RESULTS: Both challenges increased IL-5 and IL-13 in nasal fluids and serum and resulted in altered nasal cell expression of gene modules related to mucosal biology and transcriptional regulation. Changes in gene modules, more so than cytokine measurements, showed significant associations with total nasal symptom score and peak nasal inspiratory flow. Overall, EEC exposure generated larger responses and more early terminations compared with NAC. Although the 2 challenges did not correlate in symptom magnitude or temporality, striking correlations were observed in cytokine levels.
CONCLUSIONS: Although clinical outcomes of NAC and EEC were temporally different and nonequivalent in magnitude, immunologic responses were similar. Selection of a particular allergen challenge method should depend on considerations of study objectives and cost.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Entities:  

Keywords:  Fel d1; Nasal allergen challenge; cat allergy; cat dander; environmental exposure chamber; epithelium; peak nasal inspiratory flow; total nasal symptom score

Mesh:

Substances:

Year:  2020        PMID: 32169380      PMCID: PMC8958045          DOI: 10.1016/j.jaci.2020.02.024

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  22 in total

1.  Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.

Authors:  Guy W Scadding; Moises A Calderon; Virginia Bellido; Gitte Konsgaard Koed; Niels-Christian Nielsen; Kaare Lund; Alkis Togias; Deborah Phippard; Laurence A Turka; Trevor T Hansel; Stephen R Durham; Peter Adler Wurtzen
Journal:  J Immunol Methods       Date:  2012-06-30       Impact factor: 2.303

Review 2.  Environmental exposure unit: a sensitive, specific, and reproducible methodology for allergen challenge.

Authors:  Anne K Ellis; Michelle L North; Terry Walker; Lisa M Steacy
Journal:  Ann Allergy Asthma Immunol       Date:  2013-11       Impact factor: 6.347

3.  Comparison of allergic rhinitis outcomes of the environmental exposure unit and nasal allergen challenge model.

Authors:  Mark W Tenn; Lisa M Steacy; Daniel E Adams; Terry J Walker; Anne K Ellis
Journal:  Ann Allergy Asthma Immunol       Date:  2019-04-06       Impact factor: 6.347

Review 4.  Nasal allergen challenge studies of allergic rhinitis: a guide for the practicing clinician.

Authors:  Mena Soliman; Michelle L North; Lisa M Steacy; Jenny Thiele; Daniel E Adams; Anne K Ellis
Journal:  Ann Allergy Asthma Immunol       Date:  2014-09       Impact factor: 6.347

5.  Synchronous immune alterations mirror clinical response during allergen immunotherapy.

Authors:  Amedee Renand; Mohamed H Shamji; Kristina M Harris; Tielin Qin; Erik Wambre; Guy W Scadding; Peter A Wurtzen; Stephen J Till; Alkis Togias; Gerald T Nepom; William W Kwok; Stephen R Durham
Journal:  J Allergy Clin Immunol       Date:  2017-11-09       Impact factor: 10.793

6.  Inflammatory mediators in late antigen-induced rhinitis.

Authors:  R M Naclerio; D Proud; A G Togias; N F Adkinson; D A Meyers; A Kagey-Sobotka; M Plaut; P S Norman; L M Lichtenstein
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

7.  Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa.

Authors:  Wei Wang; Yan Li; Zhe Lv; Yan Chen; Yun Li; Kewu Huang; Chris J Corrigan; Sun Ying
Journal:  J Immunol       Date:  2018-09-05       Impact factor: 5.422

8.  Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.

Authors:  G W Scadding; A O Eifan; M Lao-Araya; M Penagos; S Y Poon; E Steveling; R Yan; A Switzer; D Phippard; A Togias; M H Shamji; S R Durham
Journal:  Allergy       Date:  2015-04-06       Impact factor: 13.146

9.  Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children.

Authors:  Matthew C Altman; Michelle A Gill; Elizabeth Whalen; Denise C Babineau; Baomei Shao; Andrew H Liu; Brett Jepson; Rebecca S Gruchalla; George T O'Connor; Jacqueline A Pongracic; Carolyn M Kercsmar; Gurjit K Khurana Hershey; Edward M Zoratti; Christine C Johnson; Stephen J Teach; Meyer Kattan; Leonard B Bacharier; Avraham Beigelman; Steve M Sigelman; Scott Presnell; James E Gern; Peter J Gergen; Lisa M Wheatley; Alkis Togias; William W Busse; Daniel J Jackson
Journal:  Nat Immunol       Date:  2019-04-08       Impact factor: 25.606

10.  Local and systemic effects of cat allergen nasal provocation.

Authors:  G W Scadding; A Eifan; M Penagos; A Dumitru; A Switzer; O McMahon; D Phippard; A Togias; S R Durham; M H Shamji
Journal:  Clin Exp Allergy       Date:  2015-03       Impact factor: 5.018

View more
  7 in total

1.  Endotype of allergic asthma with airway obstruction in urban children.

Authors:  Matthew C Altman; Agustin Calatroni; Sima Ramratnam; Daniel J Jackson; Scott Presnell; Mario G Rosasco; Peter J Gergen; Leonard B Bacharier; George T O'Connor; Megan T Sandel; Meyer Kattan; Robert A Wood; Cynthia M Visness; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2021-03-10       Impact factor: 10.793

Review 2.  Allergen Immunotherapy: Biomarkers and Clinical Outcome Measures.

Authors:  Constantinos Pitsios
Journal:  J Asthma Allergy       Date:  2021-02-18

3.  Dosing intact birch pollen grains at the air-liquid interface (ALI) to the immortalized human bronchial epithelial cell line BEAS-2B.

Authors:  Joana Candeias; Carsten B Schmidt-Weber; Jeroen Buters
Journal:  PLoS One       Date:  2021-11-16       Impact factor: 3.240

4.  Epithelial Aryl Hydrocarbon Receptor Protects From Mucus Production by Inhibiting ROS-Triggered NLRP3 Inflammasome in Asthma.

Authors:  Xinyue Hu; Yingchun Shen; Yilin Zhao; Ji Wang; Xin Zhang; Wei Tu; William Kaufman; Juntao Feng; Peisong Gao
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

Review 5.  Study of Cat Allergy Using Controlled Methodology-A Review of the Literature and a Call to Action.

Authors:  Lubnaa Hossenbaccus; Sophia Linton; Rashi Ramchandani; Alyssa G Burrows; Anne K Ellis
Journal:  Front Allergy       Date:  2022-03-17

Review 6.  Allergen provocation tests in respiratory research: building on 50 years of experience.

Authors:  Gail M Gauvreau; Beth E Davis; Guy Scadding; Louis-Philippe Boulet; Leif Bjermer; Adam Chaker; Donald W Cockcroft; Barbro Dahlén; Wyste Fokkens; Peter Hellings; Nikolaos Lazarinis; Paul M O'Byrne; Ellen Tufvesson; Santiago Quirce; Maurits Van Maaren; Frans H de Jongh; Zuzana Diamant
Journal:  Eur Respir J       Date:  2022-08-25       Impact factor: 33.795

7.  Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2.

Authors:  Daniel J Jackson; William W Busse; Leonard B Bacharier; Meyer Kattan; George T O'Connor; Robert A Wood; Cynthia M Visness; Stephen R Durham; David Larson; Stephane Esnault; Carole Ober; Peter J Gergen; Patrice Becker; Alkis Togias; James E Gern; Mathew C Altman
Journal:  J Allergy Clin Immunol       Date:  2020-04-22       Impact factor: 10.793

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.